Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test
Author(s) -
Shiho Takashima,
Jun Kato,
Sakiko Hiraoka,
Asuka Nakarai,
Daisuke Takei,
Toshihiro Inokuchi,
Yuusaku Sugihara,
Masahiro Takahara,
Keita Harada,
Hiroyuki Okada,
Takehiro Tanaka,
Kazuhide Yamamoto
Publication year - 2015
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.1038/ajg.2015.66
Subject(s) - calprotectin , feces , medicine , gastroenterology , ulcerative colitis , area under the curve , colonoscopy , area under curve , colorectal cancer , microbiology and biotechnology , biology , pharmacokinetics , inflammatory bowel disease , cancer , disease
We previously showed that a quantitative fecal immunochemical test (FIT) can predict mucosal healing (MH) in ulcerative colitis (UC). Fecal calprotectin (Fcal) has also been reported as an important biomarker of UC activity. The aim of this study was to compare the predictive ability of these two fecal markers for MH in UC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom